Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07847892
Long-Term Follow-Up Study of Gamgertamig
Sponsor: Lakefront Biotherapeutics West LLC
View on ClinicalTrials.gov
Summary
This study will follow adults who previously received gamgertamig in another clinical study to evaluate long-term safety and clinical outcomes.
Official title: A Multicenter, Long-Term Follow-Up Study in Participants Who Previously Participated in a Gamgertamig (OM336) Parent Clinical Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-10
Completion Date
2029-12
Last Updated
2026-09-29
Healthy Volunteers
No
Conditions
Interventions
OTHER
Observational
Prior treatment with gamgertamig in an eligible parent study. No gamgertamig is administered in this follow-up study.